Zobrazeno 1 - 10
of 41
pro vyhledávání: '"R. Mouzo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Mouzo, V. Lombardi, J.C. Diez Baylon, H.R. Avellaneda, F. Simal, J. Paniagua, B. Leon, M. Prieto, Hospital El Bierzo
Publikováno v:
Nephrology Dialysis Transplantation. 31:i300-i300
Autor:
X A, Alvarez, R, Mouzo, V, Pichel, P, Pérez, M, Laredo, L, Fernández-Novoa, L, Corzo, R, Zas, M, Alcaraz, J J, Secades, R, Lozano, R, Cacabelos
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 21(9)
Cytidine 5'-diphosphocholine (citicoline) is a an endogenous intermediate in the biosynthesis of structural membrane phospholipids and brain acetylcholine. Citicoline has been extensively used for the treatment of neurodegenerative disorders associat
Autor:
P. Pérez, X. A. Álvarez, R. Cacabelos, A. Sellers, M. Laredo, R. Mouzo, V. M. Pichel, J. M. Caamaño
Publikováno v:
Advances in Behavioral Biology ISBN: 9781461374350
Senile Dementia (SD) represents a problem of growing interest because of its increased prevalence in occidental countries. At present the prevalence of SD is about ten times higher than that detected at the beginning of this century (Cacabelos, 1991)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75bf511bd5bc6f637e3358bbc260d15d
https://doi.org/10.1007/978-1-4615-5337-3_116
https://doi.org/10.1007/978-1-4615-5337-3_116
Autor:
A. Sellers, R. Cacabelos, J. I. Lao, J. M. Caamaño, R. Mouzo, J. C. Bustos, L. Pérez, B. Rodriguez, Katrin Beyer, P. Pérez, C. Carrera, X. A. Álvarez
Publikováno v:
Advances in Behavioral Biology ISBN: 9781461374350
Behavioral changes, mood-related disturbances and sleep disorders are the major cause of institutionalization and caregiver concern in families with Alzheimer’s disease (AD) (Rabins et al., 1982; Steele et al., 1990; Morris et al., 1996). The estim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::772349536d8b3e44f54fe62c2f4c07d8
https://doi.org/10.1007/978-1-4615-5337-3_44
https://doi.org/10.1007/978-1-4615-5337-3_44
Autor:
X A, Alvarez, M, Laredo, D, Corzo, L, Fernández-Novoa, R, Mouzo, J E, Perea, D, Daniele, R, Cacabelos
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 19(3)
Citicoline is a choline donor involved in the biosynthesis of brain phospholipids and acetylcholine extensively used in the treatment of neurodegenerative diseases. In this study we investigated the effects of the oral administration of citicoline al
Autor:
L, Parra Muntaner, S, Gómez Cisneros, M, Monsalve Rodríguez, S, Kilani Elmasri, R, Mouzo Rico, S, Valerdiz Casasola, M, Orduña Yañez, M, Pont Ferrer, J, García Alonso
Publikováno v:
Archivos espanoles de urologia. 47(7)
Publikováno v:
Nephrology Dialysis Transplantation.
In order to control aluminium toxicity in dialysis patients it is preferable to prevent or limit exposure to it. However, it is sometimes necessary to remove the aluminium by the use of appropriate techniques. The collateral effects of desferrioxamin
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 9(10)
In order to control aluminium toxicity in dialysis patients it is preferable to prevent or limit exposure to it. However, it is sometimes necessary to remove the aluminium by the use of appropriate techniques. The collateral effects of desferrioxamin